Effects of CD/5-FC suicide gene therapy system on human malignant glioma cells in vitro

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 5, 2003, Pages 430-434

  Lv, Sheng Qing ^a,b   Yang, Hui ^b   He, Jia Quan ^b   Wang, Bin ^b   Yoshimura, Ichiro ^c   Liu, Yun Sheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

5 fluorocytosine; Cytosine deaminase; Gene therapy; Malignant glioma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOSINE DEAMINASE; FLUCYTOSINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EUKARYOTE; GENE EXPRESSION; GENE INSERTION; GENE ISOLATION; GENE SEQUENCE; GENETIC TRANSFECTION; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; MOLECULAR CLONING; PLASMID; RESTRICTION MAPPING; SUICIDE GENE THERAPY;

CELL DEATH; CELL DIVISION; CULTURE MEDIA; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GENE THERAPY; GENETIC VECTORS; GLIOMA; HUMANS; NUCLEOSIDE DEAMINASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EUKARYOTA; INSERTION SEQUENCES; VECTORS;

EID: 0038825837     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Yazawa K, Fisher WE, Brunicardi FC. Current progress in suicide gene therapy for cancer. World J Surg, 2002, 26(7): 783-789
2. Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA, 1994, 91(17): 8302-8306
3. Yoshimura I, Suzuki S, Tadakuma T, Hayakawa M. Suicide gene therapy on LNCaP human prostate cancer cells. Int J Urol, 2001, 8: S5-S8
4. Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high-grade gliomas: a systematic review and metaanalysis of individual patient data from 12 randomised trials. Lancet, 2002, 359: 1011-1018
5. Gutin PH, Posner JB. Neuro-oncology: diagnosis and management of cerebral gliomas - past, present, and future. Naurosurgery, 2000, 47(1): 1-8
6. Andratschke N, Grosu AL, Molls M, Nieder C. Perspectives in the treatment of malignant gliomas in adults. Anticancer Res, 2001, 21(5): 3541-3550
7. Puduvalli VK, Sawaya R. Antiangiogenesis - therapeutic strategies and clinical implications for brain tumors. J Neurooncol, 2000, 50(1-2): 189-200
8. Austin EA, Huber BE. A first step in development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol, 1993, 43(3): 380-387
9. Myers CE. The pharmacology of the fluoropyrimidines. Pharmacol Rev, 1981, 33: 1-15
10. Barba D, Hardin J, Gage FH. Thymidine kinase mediated killing of rat brain tumors. J Neurosurg, 1993, 79: 729-735
11. Sambrook J, Fvitsch EF, Maniatis T. Molecular cloning: A Laboratory Mannual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989
12. Kim R, Tanabe K, Inoue H, Toge T. Mechanism (s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Int J Oncol, 2002, 20(3): 549-555